Butyrolactone I ≥99% (by TLC)

Supplier: Enzo Life Sciences

BML-CC210-0200 BML-CC210-1000
89156-910EA 163.5 USD
89156-910 89156-912
Butyrolactone I ≥99% (by TLC)
Butyrolactone I

CDK inhibitor


Cell permeable and selective inhibitor of the cyclin-dependent kinases CDK1/cyclin B, CDK2 and CDK5. Inhibits cell cycle progression at the G1/S and G2/M transitions. G1/S and G2/M transitions, in W138 cells, were inhibited, concurrent with inhibition of the phosphorylations of, respectively, retinoblastoma protein and histone H1. It is an important tool for probing the cellular roles of CDKs. Blocks Fas-induced apoptosis. Displays antitumor activity.

Formula: C₂₄H₂₄O₇
MDL Number: MFCD03453074
CAS Number: 87414-49-1
https://digitalassets.avantorsciences.com/adaptivemedia/rendition?id=760d9afa3a838ec8c0d292e5d22c7d424b096491&vid=1800a8751737119e967ae48dedc988eb6c4b640f&prid=web&clid=SAPDAM

Order Now

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR